These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35364768)

  • 1. Bilateral facial palsy after COVID-19 vaccination.
    Andreozzi V; D'arco B; Pagliano P; Toriello A; Barone P
    Neurol Sci; 2022 Jul; 43(7):4069-4079. PubMed ID: 35364768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral facial palsy with paresthesias, variant of Guillain-Barré syndrome following COVID-19 vaccine: A case series of 9 patients.
    Castiglione JI; Crespo JM; Lecchini L; Silveira FO; Luis MB; Cotti N; Simison CJ; Aguirre F; Piedrabuena MA; Alonso RN; Azcona CL; Sosa PS; Maldonado E; Barroso F
    Neuromuscul Disord; 2022 Jul; 32(7):572-574. PubMed ID: 35644722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
    Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
    Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report.
    Rossetti A; Gheihman G; O'Hare M; Kosowsky JM
    J Emerg Med; 2021 Dec; 61(6):e141-e145. PubMed ID: 34538679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome after COVID-19 vaccination.
    McKean N; Chircop C
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination.
    Allen CM; Ramsamy S; Tarr AW; Tighe PJ; Irving WL; Tanasescu R; Evans JR
    Ann Neurol; 2021 Aug; 90(2):315-318. PubMed ID: 34114269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021.
    Lehmann HC; Oberle D; Keller-Stanislawski B; Rieck T; Streit R
    Euro Surveill; 2023 Jun; 28(24):. PubMed ID: 37318764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome presenting with facial diplegia following COVID-19 vaccination in two patients.
    Kanabar G; Wilkinson P
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34649856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré Syndrome and COVID-19 Vaccine: A Multicenter Retrospective Study of 46 Cases.
    Castiglione JI; Crespo JM; Bendersky M; Silveira FO; Lecchini L; Luis MB; Zambrano FC; Cotti N; Simison CJ; Aguirre F; Piedrabuena MA; Alonso RN; Azcona CL; Sosa PS; Maldonado E; Varela F; Bettini M; Rey RD; Cejas LL; Rugiero M; Reisin R; Barroso F
    J Clin Neuromuscul Dis; 2023 Sep; 25(1):1-10. PubMed ID: 37611264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review.
    Lee HY; Lien WC
    Hum Vaccin Immunother; 2023 Dec; 19(1):2171231. PubMed ID: 36919452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A variant of Guillain-Barré syndrome with prominent bilateral peripheral facial nerve palsy--facial diplegia and paresthesias].
    Atsumi M; Kitaguchi M; Nishikawa S; Susuki K
    Rinsho Shinkeigaku; 2004 Aug; 44(8):549-52. PubMed ID: 15471093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database.
    Keh RYS; Scanlon S; Datta-Nemdharry P; Donegan K; Cavanagh S; Foster M; Skelland D; Palmer J; Machado PM; Keddie S; Carr AS; Lunn MP;
    Brain; 2023 Feb; 146(2):739-748. PubMed ID: 35180300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.
    Walker JL; Schultze A; Tazare J; Tamborska A; Singh B; Donegan K; Stowe J; Morton CE; Hulme WJ; Curtis HJ; Williamson EJ; Mehrkar A; Eggo RM; Rentsch CT; Mathur R; Bacon S; Walker AJ; Davy S; Evans D; Inglesby P; Hickman G; MacKenna B; Tomlinson L; Ca Green A; Fisher L; Cockburn J; Parry J; Hester F; Harper S; Bates C; Evans SJ; Solomon T; Andrews NJ; Douglas IJ; Goldacre B; Smeeth L; McDonald HI
    Vaccine; 2022 Jul; 40(32):4479-4487. PubMed ID: 35715350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
    Hilts A; Schreiber A; Singh A
    Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
    Oo WM; Giri P; de Souza A
    J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated facial diplegia in Guillain-Barré syndrome: Bifacial weakness with paresthesias.
    Wakerley BR; Yuki N
    Muscle Nerve; 2015 Dec; 52(6):927-32. PubMed ID: 26315943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
    Dang YL; Bryson A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome after COVID-19 vaccines: A Tunisian case series.
    Berrim K; Lakhoua G; Zaiem A; Charfi O; Aouinti I; Kastalli S; Daghfous R; El Aidli S
    Br J Clin Pharmacol; 2023 Feb; 89(2):574-578. PubMed ID: 36398559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barre syndrome following COVID-19 vaccines: A review of literature.
    Yu M; Nie S; Qiao Y; Ma Y
    Front Immunol; 2023; 14():1078197. PubMed ID: 36875094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barré Syndrome.
    Meo SA; Shaikh N; Abukhalaf FA; Meo AS
    Sci Rep; 2024 Aug; 14(1):18767. PubMed ID: 39138276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.